Ҵý

Feature Channels: Drugs and Drug Abuse

Filters close
Go to Advanced Search
Released: 2-May-2025 11:00 AM EDT
Medicaid Unwinding Linked to Disruptions in Opioid Addiction Treatment
Michigan Medicine - University of Michigan

The national effort to return the Medicaid enrollment process to its pre-pandemic rules starting in April 2023 may have disrupted the care of people receiving treatment for opioid addiction, a new study finds. The data have implications for current Medicaid budget discussions.

Ҵý: Two HSS Studies Exploring Pain Control Win President’s Choice Awards at Annual ASRA Meeting
Released: 2-May-2025 9:30 AM EDT
Two HSS Studies Exploring Pain Control Win President’s Choice Awards at Annual ASRA Meeting
Hospital for Special Surgery

Two HSS studies received awards from the American Society of Regional Anesthesia and Pain Medicine. One looked at the prevalence of CBD use in patients scheduled for sports medicine surgery. The other compared the need for opioid medication after robotic, computer-assisted or manual hip replacement.

Released: 1-May-2025 6:30 PM EDT
Poison Centers Observe Increased Vitamin A Exposures in Children During Measles Outbreak
Rutgers University-New Brunswick

America’s Poison Centers is monitoring the National Poison Data System (NPDS) for cases of Vitamin A toxicity. Between January 1 and March 31, 2025, there have been 86 pediatric Vitamin A exposures reported to U.S. Poison Centers representing a 38.7% increase compared to the same period in 2024.

Not for public release

This news release is embargoed until 28-Apr-2025 5:00 PM EDT Released to reporters: 22-Apr-2025 7:45 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Apr-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 28-Apr-2025 9:25 AM EDT
Impact of Computer-Mediated Versus Face-to-Face Motivational-Type Interviews on Participants’ Language and Subsequent Cannabis Use: Randomized Controlled Trial
Journal of Medical Internet Research

Background: Motivational interviewing (MI) is frequently used to facilitate behavior change. The use of change talk during motivational interviews can predict subsequent behavior change. However, no studies have compared the informat...

Ҵý: Using a Pea-Sized Node in the Brain to Potentially Treat Drug Addiction
Released: 23-Apr-2025 5:50 PM EDT
Using a Pea-Sized Node in the Brain to Potentially Treat Drug Addiction
Rockefeller University

Ines Ibañez-Tallon is revealing how an understudied region of the brain plays an outsized role in opioid and nicotine dependence.

Not for public release

This news release is embargoed until 21-Apr-2025 5:00 PM EDT Released to reporters: 15-Apr-2025 7:55 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Apr-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Apr-2025 5:55 PM EDT
New Surgical Research in April: Preoperative Weight Loss, Opioid Stewardship, Motion Tracking for Surgical Education, and More
American College of Surgeons (ACS)

The April issue of the Journal of the American College of Surgeons (JACS), which includes research presented at the Southern Surgical Association 136th Annual Meeting, features new findings.

Ҵý: LLNL Scientists Use AI to Optimize Antibodies to Combat Future Mutations and Accelerate Pandemic Preparedness
Released: 7-Apr-2025 1:00 PM EDT
LLNL Scientists Use AI to Optimize Antibodies to Combat Future Mutations and Accelerate Pandemic Preparedness
Lawrence Livermore National Laboratory

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to neutralize a broad diversity of SARS-CoV-2 variants.

Ҵý: 1920_gettyimages-2120556949.jpg?10000
Released: 7-Apr-2025 11:10 AM EDT
Hospitalization Offers Chance to Begin Treatment for Patients With Opioid Use Disorder
Cedars-Sinai

Patients hospitalized with opioid use disorders who receive addiction consultation services are significantly more likely to start medication treatment and access follow-up care when compared with patients who receive standard or usual care, a study co-led by Cedars-Sinai investigators found.

Not for public release

This news release is embargoed until 4-Apr-2025 10:15 AM EDT Released to reporters: 4-Apr-2025 10:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Apr-2025 10:15 AM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 4-Apr-2025 10:00 AM EDT Released to reporters: 31-Mar-2025 7:35 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Apr-2025 10:00 AM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Ҵý: Mount Sinai Launches AI Small Molecule Drug Discovery Center
Released: 2-Apr-2025 9:00 AM EDT
Mount Sinai Launches AI Small Molecule Drug Discovery Center
Mount Sinai Health System

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development. The new Center will integrate AI with traditional drug discovery methods to identify and design new small-molecule therapeutics with unprecedented speed and precision. Unlike conventional drug discovery, which can take years and cost billions, AI-driven approaches enable researchers to rapidly navigate a vast chemical landscape, including natural products, to pinpoint promising drug candidates. By leveraging Mount Sinai’s world-leading expertise in machine learning, chemical biology, and biomedical data science, the Center aims to bring innovative treatments to patients faster—particularly for diseases with urgent unmet needs, including cancer, metabolic disorders, and neurodegenerative diseases.

Released: 31-Mar-2025 9:05 AM EDT
Enhanced Recovery Pathways Slash Opioid Prescriptions in Iowa Hospitals
The Rothman Orthopaedic Institute Foundation for Opioid Research and Education

recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways. The study, led by researchers from the Rothman Opioid Foundation, Goldfinch Health, and Drexel University College of Medicine, examined the impact of ERAS protocols on opioid prescribing to patients undergoing arthroplasty (joint replacement surgery) and arthroscopy (a minimally invasive procedure to diagnose and treat joint issues). Arthroplasty involves replacing damaged joints with prosthetic implants to relieve pain and restore function, whereas arthroscopy utilizes a small camera to examine and repair joint damage through small incisions.

Ҵý: Young Adults in Pain Start Using Cannabis Earlier and Are More Likely to Mix It with Alcohol
Released: 26-Mar-2025 7:50 PM EDT
Young Adults in Pain Start Using Cannabis Earlier and Are More Likely to Mix It with Alcohol
Binghamton University, State University of New York

Young adults in pain start using cannabis earlier and are more likely to mix it with alcohol, according to new research from Binghamton University, State University of New York.

Ҵý: Xylazine Detected in U.S.-Mexico Border Drug Supply, Study Finds
Released: 20-Mar-2025 11:00 AM EDT
Xylazine Detected in U.S.-Mexico Border Drug Supply, Study Finds
University of California San Diego

Researchers at UC San Diego have confirmed the presence of xylazine in the illicit drug supply at the U.S.-Mexico border. While xylazine remains less common in the Western U.S., border cities serve as key trafficking hubs and may have higher rates of emerging substances.

Not for public release

This news release is embargoed until 17-Mar-2025 5:00 PM EDT Released to reporters: 11-Mar-2025 8:50 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Mar-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-Mar-2025 8:45 PM EDT
Prevention is the Strongest Antidote for Poisoning
Rutgers University-New Brunswick

The NJ Poison Control Center Urges Implementing Poison Safety Practices at Home During National Poison Prevention Week



close
2.01117